Latest News and Press Releases

Press Release 4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and...

Press Release 4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and...

Press Release LONDON, 4 November 2024 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm focused solely on the advanced and emerging therapies sector, announces today the...

Press Release LONDON, 4 November 2024 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm focused solely on the advanced and emerging therapies sector, announces today the...

March Bio is rapidly advancing its innovative autologous chimeric antigen receptor T-cell (CAR-T) therapy, MB-105, in development for the treatment of relapsed and refractory CD5 positive T-cell...

Press Release Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus (EBV) driven disease 4BIO Capital...

Press Release 4BIO Capital Strengthens Advisory Board and Investment Team Industry veteran and former CEO of Vifor Pharma Abbas Hussain and world leading vectorology expert and LogicBio...

Press Release Development Bank of Japan invests in 4BIO Capital’s Ventures III fund 4BIO Ventures III targeting $200-300 million to unlock the treatments of the future by investing in advanced...

Press Release Development Bank of Japan invests in 4BIO Capital’s Ventures III fund 4BIO Ventures III targeting $200-300 million to unlock the treatments of the future by investing in advanced...

Press Release 4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases Series A follows initial seed...